These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 14760861)

  • 21. Structure-activity relationship of a series of nitrogen mustard- and pyrrole-containing minor groove-binding agents related to distamycin.
    Wyatt MD; Garbiras BJ; Haskell MK; Lee M; Souhami RL; Hartley JA
    Anticancer Drug Des; 1994 Dec; 9(6):511-25. PubMed ID: 7880376
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis and reactivity of aryl nitrogen mustard-oligodeoxyribonucleotide conjugates.
    Reed MW; Lukhtanov EA; Gorn V; Kutyavin I; Gall A; Wald A; Meyer RB
    Bioconjug Chem; 1998; 9(1):64-71. PubMed ID: 9460548
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis, biological evaluation and molecular docking studies of amide-coupled benzoic nitrogen mustard derivatives as potential antitumor agents.
    Zheng QZ; Zhang F; Cheng K; Yang Y; Chen Y; Qian Y; Zhang HJ; Li HQ; Zhou CF; An SQ; Jiao QC; Zhu HL
    Bioorg Med Chem; 2010 Jan; 18(2):880-6. PubMed ID: 20005116
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Benzoyl nitrogen mustard derivatives of benzoheterocyclic analogues of netropsin: synthesis and biological activity.
    Baraldi PG; Romagnoli R; Bianchi N; Gambari R
    Bioorg Med Chem; 2003 May; 11(11):2381-8. PubMed ID: 12735983
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis of half-mustard combi-molecules with fluorescence properties: correlation with EGFR status.
    Rachid Z; Brahimi F; Domarkas J; Jean-Claude BJ
    Bioorg Med Chem Lett; 2005 Feb; 15(4):1135-8. PubMed ID: 15686928
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Potent antitumor 9-anilinoacridines and acridines bearing an alkylating N-mustard residue on the acridine chromophore: synthesis and biological activity.
    Su TL; Lin YW; Chou TC; Zhang X; Bacherikov VA; Chen CH; Liu LF; Tsai TJ
    J Med Chem; 2006 Jun; 49(12):3710-8. PubMed ID: 16759114
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Conjugated system of homo-aza-steroidal esters in cancer chemotherapy.
    Catsoulacos P; Catsoulacos D
    Anticancer Res; 1994; 14(6B):2525-8. PubMed ID: 7872677
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis and biological activity of DNA damaging agents that form decoy binding sites for the estrogen receptor.
    Rink SM; Yarema KJ; Solomon MS; Paige LA; Tadayoni-Rebek BM; Essigmann JM; Croy RG
    Proc Natl Acad Sci U S A; 1996 Dec; 93(26):15063-8. PubMed ID: 8986764
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reductive chemistry of the novel hypoxia-selective cytotoxin 5-[N,N-bis(2-chloroethyl)amino]-2,4-dinitrobenzamide.
    Palmer BD; van Zijl P; Denny WA; Wilson WR
    J Med Chem; 1995 Mar; 38(7):1229-41. PubMed ID: 7707325
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Benzoyl and cinnamoyl nitrogen mustard derivatives of benzoheterocyclic analogues of the tallimustine: synthesis and antitumour activity.
    Baraldi PG; Romagnoli R; Giovanna Pavani M; del Carmen Nunez M; Bingham JP; Hartley JA
    Bioorg Med Chem; 2002 May; 10(5):1611-8. PubMed ID: 11886822
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthesis, DNA binding, cytotoxicity and sequence specificity of a series of imidazole-containing analogs of the benzoic acid mustard distamycin derivative tallimustine containing an alkylating group at the C-terminus.
    Brooks N; Lee M; Wright SR; Woo S; Centioni S; Hartley JA
    Anticancer Drug Des; 1997 Oct; 12(7):591-606. PubMed ID: 9365504
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Utilizing a D-amino acid as a drug carrier for antineoplastic nitrogen mustard groups.
    Bartzatt RL
    Drug Deliv; 2005; 12(3):141-7. PubMed ID: 16025843
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Steroidal esters of the aromatic nitrogen mustard 2-[4-N,N-bis(2-chloroethyl)amino-phenyl]butanoic acid (2-PHE-BU): synthesis and in-vivo biological evaluation.
    Papaconstantinou IC; Fousteris MA; Koutsourea AI; Pairas GN; Papageorgiou AD; Nikolaropoulos SS
    Anticancer Drugs; 2013 Jan; 24(1):52-65. PubMed ID: 23187313
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Structure-activity relationship of a series of C-terminus modified aminoalkyl, diaminoalkyl- and anilino-containing analogues of the benzoic acid mustard distamycin derivative tallimustine: synthesis, DNA binding and cytotoxicity studies.
    Brooks N; Hartley JA; Simpson JE; Wright SR; Woo S; Centioni S; Fontaine MD; McIntyre TE; Lee M
    Bioorg Med Chem; 1997 Aug; 5(8):1497-507. PubMed ID: 9313856
    [TBL] [Abstract][Full Text] [Related]  

  • 35. DNA sequence selectivity of guanine-N7 alkylation by nitrogen mustards.
    Mattes WB; Hartley JA; Kohn KW
    Nucleic Acids Res; 1986 Apr; 14(7):2971-87. PubMed ID: 3960738
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthesis and biological evaluation of cyclic nitrogen mustards based on carnitine framework.
    Leiris S; Lucas M; Dupuy d'Angeac A; Morère A
    Eur J Med Chem; 2010 Sep; 45(9):4140-8. PubMed ID: 20615582
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthesis and preliminary cytotoxicity of nitrogen mustard derivatives of distamycin A.
    Wang Y; Wright SC; Larrick JW
    Bioorg Med Chem Lett; 2003 Feb; 13(3):459-61. PubMed ID: 12565950
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antitumor activity and bone marrow toxicity of aminoglucose mustard anticancer agents in mice.
    Cantrell JE; Green D; Schein PS
    Cancer Res; 1986 May; 46(5):2340-3. PubMed ID: 2938728
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis and antitumor activity of novel nitrogen mustard-linked chalcones.
    Fang X; Yang B; Cheng Z; Yang M; Su N; Zhou L; Zhou J
    Arch Pharm (Weinheim); 2013 Apr; 346(4):292-9. PubMed ID: 23519571
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sequence specificity of alkylation for a series of nitrogen mustard-containing analogues of distamycin of increasing binding site size: evidence for increased cytotoxicity with enhanced sequence specificity.
    Wyatt MD; Lee M; Garbiras BJ; Souhami RL; Hartley JA
    Biochemistry; 1995 Oct; 34(40):13034-41. PubMed ID: 7548062
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.